Buprenorphine vs alpha2‐adrenergic agonists
Number with treatment stopped due to adverse effects · Adults or adolescents with opioid dependence
Buprenorphine showed no clear difference in number with treatment stopped due to adverse effects compared with alpha2‐adrenergic agonists (low certainty).
1 finding from 1 review
- RR 0.2 [0.04, 1.15]3 studies · 134 participantsLow